SCHEMBL12932293

SCHEMBL12932293

Nc1ncnc2c1ncn2C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)CC1F

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 7/20 0.66
▸ P2RX1 P51575 4/20 0.66
▸ P2RX2 Q9UBL9 3/20 0.66
▸ P2RX4 Q99571 6/20 0.64
▸ P2RY1 P47900 5/20 0.64
▸ P2RY2 P41231 2/20 0.64
▸ SRC P12931 1/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ SMN1; SMN2 Q16637 1/20 0.64
▸ RNASEL Q05823 1/20 0.61
▸ MACROD2 A1Z1Q3 1/20 0.60
▸ SIRT6 Q8N6T7 1/20 0.60
▸ MACROD1 Q9BQ69 1/20 0.60
▸ TRPM2 O94759 1/20 0.60
▸ P2RX7 Q99572 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29673204 1.00 P2RX3 (0.66) P2RX3P2RX1P2RX2P2RX4P2RY1
SCHEMBL15698480 1.00 P2RX3 (0.66) P2RX3P2RX1P2RX2P2RX4P2RY1
SCHEMBL21417366 0.91 P2RY1 (0.66) P2RY1P2RY2SRCSMN1; SMN2RNASEL
SCHEMBL20324919 0.91 P2RY1 (0.66) P2RY1P2RY2SRCSMN1; SMN2RNASEL
SCHEMBL20326922 0.91 P2RY1 (0.66) P2RY1P2RY2SRCSMN1; SMN2RNASEL
SCHEMBL20224844 0.91 P2RY1 (0.66) P2RY1P2RY2SRCSMN1; SMN2RNASEL
SCHEMBL22571185 0.90 P2RY1 (0.57) P2RX3P2RX1P2RX2P2RX4P2RY1
SCHEMBL23982340 0.90 P2RX1 (0.70) P2RX3P2RX1P2RX2P2RX4P2RY1
SCHEMBL19493160 0.90 P2RX1 (0.70) P2RX3P2RX1P2RX2P2RX4P2RY1
SCHEMBL3163036 0.90 P2RX1 (0.70) P2RX3P2RX1P2RX2P2RX4P2RY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275672-A1 CHEMICALLY MODIFIED LIGASE COFACTORS, DONORS AND ACCEPTORS TRILINK BIOTECHNOLOGIES, INC. (US) 2017-09-28 — — US disclosed
US-20170275672-A1 CHEMICALLY MODIFIED LIGASE COFACTORS, DONORS AND ACCEPTORS TRILINK BIOTECHNOLOGIES, INC. (US) 2017-09-28 — — US disclosed
US-9631227-B2 Chemically modified ligase cofactors, donors and acceptors TRILINK BIOTECHNOLOGIES, INC. (US) 2017-04-25 — — US disclosed
US-9631227-B2 Chemically modified ligase cofactors, donors and acceptors TRILINK BIOTECHNOLOGIES, INC. (US) 2017-04-25 — — US disclosed
US-20140323354-A1 Chemically Modified Ligase Cofactors, Donors and Acceptors TRILINK BIOTECHNOLOGIES, INC. (US) 2014-10-30 — — US disclosed
US-20140323354-A1 Chemically Modified Ligase Cofactors, Donors and Acceptors TRILINK BIOTECHNOLOGIES, INC. (US) 2014-10-30 — — US disclosed
WO-2014144979-A1 CHEMICALLY MODIFIED LIGASE COFACTORS, DONORS AND ACCEPTORS TRILINK BIOTECHNOLOGIES, INC. (US) 2014-09-18 — — WO disclosed
US-8728725-B2 Chemically modified ligase cofactors, donors and acceptors TRILINK BIOTECHNOLOGIES (US) 2014-05-20 — — US disclosed
US-8728725-B2 Chemically modified ligase cofactors, donors and acceptors TRILINK BIOTECHNOLOGIES (US) 2014-05-20 — — US disclosed
US-20110008788-A1 CHEMICALLY MODIFIED LIGASE COFACTORS, DONORS AND ACCEPTORS TriLink Bio Technologies 2011-01-13 — — US disclosed
US-20110008788-A1 CHEMICALLY MODIFIED LIGASE COFACTORS, DONORS AND ACCEPTORS TriLink Bio Technologies 2011-01-13 — — US disclosed
WO-2011005762-A1 CHEMICALLY MODIFIED LIGASE COFACTORS, DONORS AND ACCEPTORS TRILINK BIOTECHNOLOGIES (US) 2011-01-13 — — WO disclosed
Send feedback